SITC 2023 Supporters

SITC 2023 Supporters

SITC gratefully acknowledges the following supporters of the society's 38th Annual Meeting & Pre-Conference Programs.

38th Annual Meeting

Platinum

Amgen

Bristol Myers Squibb

Incyte Corporation

Gold

  Janssen Research & Development, LLC

Silver

Alkermes

Exelixis, Inc.

Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc.

Regeneron Pharmaceuticals, Inc.

Sanofi US Services, Inc.

Bronze

AstraZeneca Pharmaceuticals 

AstraZeneca (The CheckPoints Party)

Novartis  Pharmaceuticals Corporation

Pfizer, Inc.

Seagen

Wells Fargo

Copper

Bayer HealthCare Pharmaceuticals Inc. (Young Investigator Travel Awards)

NanoString Technologies (The CheckPoints Party)

Precision for Medicine

Pyxis Oncology (The CheckPoints Party)

UPMC Hillman Cancer Center (The CheckPoints Party)

Standard BioTools (The CheckPoints Party)


Primer on Tumor Immunology and Cancer ImmunotherapyTM

Silver

Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc.

Bronze

Incyte Corporation


Workshop on Targeting Myeloid Cells in Immuno-Oncology

Gold

Bristol Myers Squibb

Bronze

AbbVie


Approaches to Early-stage Malignancies, Driving to a Cure (SITC's Industry Program)

Gold

Bristol Myers Squibb

Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc.

Grant Writing Workshop


World Immunotherapy Council (WIC) Young Investigator Symposium

Bronze

Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc.

Pfizer, Inc.

 

Supporters as of November 1, 2023